NervGen Pharma Corp.
NGEN.V
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 14.15% | -16.11% | -22.83% | -19.87% | -13.28% |
| Total Receivables | -60.77% | -18.84% | 7,320.83% | -42.86% | -16.00% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -0.53% | -26.68% | 4.91% | -27.52% | 157.80% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 52.71% | -65.09% | 28.72% | 45.41% | -24.28% |
| Total Current Assets | 12.91% | -18.98% | -18.65% | -18.67% | -13.04% |
|
|
|||||
| Total Current Assets | 12.91% | -18.98% | -18.65% | -18.67% | -13.04% |
| Net Property, Plant & Equipment | -- | -- | -- | -26.32% | -98.53% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 2.14% | -2.88% | -8.86% | -1.56% | -3.79% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -76.42% | -41.71% | -- |
| Total Assets | 12.61% | -18.63% | -18.53% | -18.42% | -13.19% |
|
|
|||||
| Total Accounts Payable | 7.09% | -- | -- | -17.20% | -31.05% |
| Total Accrued Expenses | 22.38% | -9.59% | 58.11% | -6.15% | 18.60% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -25.66% | -15.83% | -4.65% | 2.75% | 0.44% |
| Total Finance Division Other Current Liabilities | 34.20% | -16.74% | 14.12% | -14.17% | 22.06% |
| Total Other Current Liabilities | 34.20% | -16.74% | 14.12% | -14.17% | 22.06% |
| Total Current Liabilities | 30.13% | -14.42% | 19.79% | -12.52% | 17.88% |
|
|
|||||
| Total Current Liabilities | 30.13% | -14.42% | 19.79% | -12.52% | 17.88% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -76.42% | -41.71% | -30.13% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 30.13% | -14.46% | 19.55% | -12.63% | 17.58% |
|
|
|||||
| Common Stock & APIC | 13.07% | 1.72% | -5.41% | 1.89% | -0.74% |
| Retained Earnings | -14.43% | -3.97% | -2.53% | -7.30% | -8.56% |
| Treasury Stock & Other | 8.71% | 6.24% | -0.17% | 8.43% | 5.14% |
| Total Common Equity | -169.66% | -46.02% | -73.64% | -25.55% | -34.37% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -169.66% | -46.02% | -73.64% | -25.55% | -34.37% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -169.66% | -46.02% | -73.64% | -25.55% | -34.37% |
|
|
|||||